Murine monoclonal anti-tNF antibody administration has a beneficial effect on inflammatory bowel disease that develops in IL-10 knockout mice.

Gratz, Raia; Becker, Stuart; Sokolowski, Nadia; Schumann, Marcus; Bass, David; Malnick, Stephen D H

Gratz, Raia; Becker, Stuart; Sokolowski, Nadia; Schumann, Marcus; Bass, David; Malnick, Stephen D H.

Affiliation

Gratz R; Division of Internal Medicine C, Kaplan Medical Center, Rehovot, Israel.

Dig Dis Sci ; 47(8): 1723-7, 2002 Aug.

Article in En | MEDLINE | ID: mdl-12184521

Subject(s)

Inflammatory Bowel Diseases/etiology; Interleukin-10; Tumor Necrosis Factor-alpha/physiology; Animals; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/pharmacology; Disease Models, Animal; Inflammatory Bowel Diseases/pathology; Injections, Intraperitoneal; Interleukin-10/physiology; Mice; Mice, Knockout; Tumor Necrosis Factor-alpha/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Tumor Necrosis Factor-alpha / Interleukin-10 Type of study: Prognostic_studies Limits: Animals Language: En Journal: Dig Dis Sci Year: 2002 Document type: Article Affiliation country: Israel Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links